-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Coeptis Therapeutics Holdings, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2020 to Q4 2024.
- Coeptis Therapeutics Holdings, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$2.16M, a 35.8% increase year-over-year.
- Coeptis Therapeutics Holdings, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$10.1M, a 53.2% increase year-over-year.
- Coeptis Therapeutics Holdings, Inc. annual Operating Income (Loss) for 2024 was -$10.1M, a 53.2% increase from 2023.
- Coeptis Therapeutics Holdings, Inc. annual Operating Income (Loss) for 2023 was -$21.5M, a 37.2% increase from 2022.
- Coeptis Therapeutics Holdings, Inc. annual Operating Income (Loss) for 2022 was -$34.2M, a 143% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)